As immunotherapy using an anti-ADAMTS1 antibody has been reported to be efficient against 4T1-induced tumorigenesis in mice,28 our study reinforces the idea of therapeutically targeting ADAMTS1 – and other NFAT targets – to prevent breast cancer metastasis. Here, ADAMTS1 is linked to breast carcinoma.